Geovax Labs is a biotechnology company that focuses on developing innovative vaccines and immunotherapies for infectious diseases and cancer
With a particular emphasis on addressing public health concerns, Geovax leverages its proprietary technology platform to create novel medical solutions aimed at enhancing immune responses. The company is involved in various stages of research and development, working to advance its projects through clinical trials and collaborations with other research entities, committed to improving health outcomes and combating significant health threats.
Vuzix, GeoVox Labs, and Cardiol Therapeutics emerged as notable penny stocks late in 2024 for their potential to scale operations and launch new products.
GeoVax Labs shares popped ahead of the close on Wednesday and continue to bounce around in extended trading following a report suggesting Wayne County confirmed its first case of mpox since 2022.
GeoVax entered into a definitive securities purchase agreement with a certain institutional investor for the purchase and sale of 1.7 million shares of its common stock for $5 per share in a registered direct offering priced above-the-market under Nasdaq rules.
Virax Biolabs shares are racing higher Monday as shares of mpox-related stocks climb after the World Health Organization (WHO) declared the virus a global health emergency last week. Here's a look at what's going on:
GeoVax Labs Inc (NASDAQGOVX) shares continue to rally Monday adding to gains of more than 225% over the past week. Here's a look at what you need to know.
Several healthcare stocks associated with mpox are seeing increased attention Thursday after the World Health Organization declared a public health emergency in response to an mpox outbreak in Africa.
